Skip to main content
. 2026 Aug 25;9(3):285. doi: 10.3390/reports9030285
PDAC Pancreatic Ductal Adenocarcinoma
NLR Neutrophil-to-lymphocyte ratio
ccfDNA Circulating cell-free DNA
OS Overall Survival
PFS Progression-Free Survival
CT Computed Tomography
CA19-9 Carbohydrate Antigen 19-9
CEA Carcinoembryonic Antigen
AFP Alpha-Fetoprotein
EUS-FNA Endoscopic Ultrasound-Guided Tissue Acquisition and Fine Needle Aspiration
gDNA Genomic DNA
NGS Next Generation Sequencing
5-FU 5-fluorouracil
RFS Relapse-free survival
VAFs Variant allele frequencies
TTNT Time to next treatment